IDXX
IDXX
US45168D1046
IDEXX Laboratories, Inc.
Loading chart...

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Latest News

Related stocks

ILMN
ILMN • United States
Illumina, Inc.
278.17 USD
42B USD 1Y +170.6%
NTRA
NTRA • United States
Natera, Inc.
400.71 USD
57.76B USD 1Y +127.1%
IQV
IQV • United States
IQVIA Holdings, Inc.
259.88 USD
42.78B USD 1Y +29.1%
WAT
WAT • United States
Waters Corporation
433.77 USD
42.59B USD 1Y +31%
GH
GH • United States
Guardant Health, Inc.
167.47 USD
22.47B USD 1Y +153.5%
A
A • United States
Agilent Technologies, Inc.
170.54 USD
48.08B USD 1Y +19.4%
CRL
CRL • United States
Charles River Laboratories Inte
301.79 USD
14.41B USD 1Y +71.8%
MEDP
MEDP • United States
Medpace Holdings, Inc.
612.05 USD
17.08B USD 1Y +13.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
35.6% p.a.
Max Drawdown (5Y)
-51.3%
Sharpe Ratio (5Y)
-0.17
Beta Factor
1.55
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.55 indicates above-average volatility compared to the broader market.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -54.0% in the extended horizon.
ende